# Effect of Cetrorelex Acetate on Ovarian Function in Women Undergoing Chemotherapy

> **NCT00507780** · PHASE4 · WITHDRAWN · sponsor: **Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)**

## Conditions studied

- Ovarian Function
- Preservation of Ovarian Function

## Interventions

- **DRUG:** GnRH antagonist

## Key facts

- **NCT ID:** NCT00507780
- **Lead sponsor:** Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- **Sponsor class:** NIH
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2007-07-18
- **Primary completion:** 2010-07-22
- **Final completion:** 2010-07-22
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2017-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00507780

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00507780, "Effect of Cetrorelex Acetate on Ovarian Function in Women Undergoing Chemotherapy". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00507780. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*